Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
Louis FlaméeRolf SymonsGanna DegtiarovaTom DresselaersOlivier GheysensWim WuytsJohan Van CleemputJan BogaertPublished in: European radiology (2020)
• Sarcoidosis often affects the heart. • Comprehensive CMR, including T2 imaging and LGE enhancement CMR, allows to depict both active and inactive myocardial damage. • Patient prognosis in sarcoidosis is determined by the presence and severity of myocardial involvement at LGE CMR.